Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency.

Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency.

Cellular sumoylation processes are proposed targets for anti-viral and anti-cancer therapies. We reported that Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) dysregulates cellular sumoylation processes, contributing to its oncogenic potential in EBV-associated malignancies. Ginkgolic acid...

Full description

Bibliographic Details
Main Authors: Gretchen L Bentz, Angela J Lowrey, Dustin C Horne, Vy Nguyen, Austin R Satterfield, Tabithia D Ross, Abigail E Harrod, Olga N Uchakina, Robert J McKallip
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0217578

Internet

https://doi.org/10.1371/journal.pone.0217578

Similar Items